|
|
Volumn 13, Issue 2, 2003, Pages 88-94
|
|
Cancer of the ovary
|
|
Author keywords
Borderline ovarian tumours; Ovarian carcinoma; Screening; Surgery
|
|
Indexed keywords
ALKALINE PHOSPHATASE PLACENTA ISOENZYME;
CA 125 ANTIGEN;
CA 19-9 ANTIGEN;
CARBOPLATIN;
CARCINOEMBRYONIC ANTIGEN;
CISPLATIN;
COLONY STIMULATING FACTOR 1;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GALACTOSYLTRANSFERASE;
TUMOR ANTIGEN;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER EPIDEMIOLOGY;
CANCER RISK;
CANCER SCREENING;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER SUSCEPTIBILITY;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIAGNOSTIC IMAGING;
FEMALE;
HUMAN;
OVARY CARCINOMA;
PROGNOSIS;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
TREATMENT PLANNING;
TUMOR DIFFERENTIATION;
|
|
EID: 0037378579
PISSN: 09575847
EISSN: None
Source Type: Journal
DOI: 10.1054/cuog.2002.0315 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (2)
|
